1174020-46-2 Usage
Uses
Used in Pharmaceutical Research:
cis-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate is utilized as a research compound for exploring its potential biological activities and applications in the development of new pharmaceuticals. Its unique structure, including the fluorine and hydroxyl substitutions, may confer specific properties that are valuable in medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, cis-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate serves as an intermediate in the synthesis of more complex organic molecules. Its presence of various functional groups allows for further chemical reactions, making it a versatile building block for the creation of pharmaceuticals, agrochemicals, or other specialty chemicals.
Used in Medicinal Chemistry:
cis-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate is employed as a starting material or a key component in the design and synthesis of new drug candidates. Its structural features may contribute to the development of compounds with improved pharmacokinetic and pharmacodynamic profiles, enhancing their therapeutic potential.
Used in Drug Development:
In the pharmaceutical industry, cis-tert-butyl 4-fluoro-3-hydroxypiperidine-1-carboxylate is used as a precursor in the development of new drugs. Its complex structure and functional groups provide a foundation for the creation of molecules with specific therapeutic targets, potentially leading to innovative treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1174020-46-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,7,4,0,2 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1174020-46:
(9*1)+(8*1)+(7*7)+(6*4)+(5*0)+(4*2)+(3*0)+(2*4)+(1*6)=112
112 % 10 = 2
So 1174020-46-2 is a valid CAS Registry Number.
1174020-46-2Relevant academic research and scientific papers
1 -OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
-
Page/Page column 31, (2016/06/28)
1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.
NOVEL HETEROCYCLYL COMPOUNDS
-
Page/Page column 26-27, (2011/05/03)
The invention is concerned with novel bicyclic compounds of formula (I), wherein n, m, p, A, L, R1, R2, R3, R4, R5, R6, R7, R7, R8, R9, and R10 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor may be used, for example, in the prevention and/or treatment of inflammatory diseases, particularly peripheral arterial occlusive diseases or atherothrombosis.
DIAZEPAM DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 61, (2011/05/06)
The invention is concerned with novel bicyclic compounds of Formula (I), wherein n, m, p, A, L, R1, R2, R3, R4, R5, R6, R7, R7, R8, R9 and R10 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR2 receptor, CCR5 receptor and/or CCR3 receptor and can be used as medicaments.
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
, (2009/12/23)
Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
